Case of corneal melting associated with the use of topical Nepafenac

Cornea

Volumn 26, Issue 8, 2007, Pages 1002-1003

  Bekendam, Peter D ^a   Narváez, Julio ^a   Agarwal, Madhu ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Corneal melt; Nepafenac; Nonsteroidal anti inflammatory agents

Indexed keywords

ERYTHROMYCIN; NEPAFENAC; PROMETHAZINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORNEA INJURY; CORNEA ULCER; DRUG WITHDRAWAL; EYE PAIN; FEMALE; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENEACETAMIDES; CORNEA; CORNEAL ULCER; DECOMPRESSION, SURGICAL; FEMALE; HUMANS; MIDDLE AGED; PAIN; PHENYLACETATES;

EID: 34548292585     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3180cfe626     Document Type: Article

References (13)

1. Congdon NG, Schein OD, Kulajta PV, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs. J Cataract Refract Surg. 2001;27:622-631.
2. Asai T, Nakagami T, Mochizuki M, et al. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Cornea. 2006;25:393-394.
3. Mian SI, Gupta A, Pineda R. Corneal ulceration and perforation with ketorolac tromethamine use after PRK. Cornea. 2006;25:232-234.
4. Gabison EE, Chastang P, Menashi S, et al. Late corneal perforation after photorefractive keratectomy associated with topical diclofenac: involvement of matrix metalloproteinases. Ophthalmology. 2003;110:1626-1631.
5. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc. 2001;99:205-212.
6. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 2001;108:936-944.
7. Lin JC, Rapuano CJ, Laibson PR, et al. Corneal melting associated with the use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol. 2000;118:1129-1132.
8. O'Brien TP, Li QJ, Saueburger F, et al. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology. 2001;108:656-659.
9. Reviglio VE, Rana TS, Li QJ, et al. Effects of topical nonsteroidal antiinflammatory drugs on the expression of matrix metalloproteinases in the cornea. J Cataract Refract Surg. 2003;29:989-997.
10. Hargrave SL, Jung JC, Fini ME, et al. Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting. Ophthalmology. 2002;109:343-350.
11. Takahashi N, Miyakoshi M, Taka N, et al. Cytotoxic effects of diclofenac sodium. Nippon Ganka Gakkai Zasshi. 1993;97:145-149.
12. Sun R, Gimbel HV. Effects of topical ketorolac and diclofenac on normal corneal sensation. J Refract Surg. 1997;13:158-161.
13. Chen X, Gallar J, Belmonte C. Reduction by antiinflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation. Invest Ophthalmol Vis Sci. 1997;38:1944-1953.